View the Latest: Over-the-Counter Contraceptives
Filter
-
-
Over-the-Counter Oral Contraceptive Pills
Issue BriefOral contraceptives are the most commonly used method of reversible contraception in the U.S. In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.
-
Pharmacies as an Access Point for Expanding Contraceptive Care: A Geographic Analysis
Issue BriefIn this brief, we explore avenues for expanding hormonal contraceptive care and supplies through pharmacies, as well as how and where pharmacies and pharmacists may be positioned to fill gaps in contraceptive care where there are few brick-and-mortar family planning providers, as well as the challenges in expanding these pathways.
-
Emergency Contraception
Fact SheetThis fact sheet reviews current national and state policies around Emergency Contraception, including methods, patient awareness, access and availability, and insurance coverage. Among methods discussed are ulipristal acetate (ella), intrauterine devices (copper IUDs and levonorgestrel IUDs), and progestin-based pills (Plan B and Next Choice).
-
Contraceptive Experiences, Coverage, and Preferences: Findings from the 2024 KFF Women’s Health Survey
Issue BriefThis brief offers a close examination of women's experiences with contraception, insurance coverage, contraceptive preferences, and interactions with the health care system. We also explore the influence and reach of contraceptive information on social media.
-
How Could the New Biden Regulations Affect Contraceptive Coverage?
Quick TakeThe Biden administration just proposed a new regulation intended to expand contraceptive coverage and make it easier for women to get their preferred contraceptive covered.
-
3 Charts: The Cost and Coverage of Opill—the First FDA-approved Over-the-Counter Daily Oral Contraceptive Pill in the United States
News ReleaseThe first FDA-approved over-the-counter daily oral contraceptive pill in the United States— Perrigo’s Opill— is now available for pre-order at major online retailers and will soon be available in stores.
-
KFF Examines Key Considerations for the Implementation of Insurance Coverage for Over-the-Counter Contraceptives
News ReleaseWith federal regulators seeking public input on the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover over-the-counter preventive products without a prescription, a new KFF post explores the issues relevant to covering over-the-counter contraceptives.
-
Considerations for Covering Over-the-Counter Contraception
Policy WatchIn October 2023, the Departments of the Treasury, Labor, and Health and Human Services issued a request for information to gather public input about the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover OTC preventive services and supplies without a prescription. This policy watch addresses key considerations for the implementation of insurance coverage for non-prescribed OTC contraceptives based on the lessons learned from KFF’s 2023 study of Insurance Coverage of OTC Oral Contraceptives.
-
KFF Examines Challenges in Navigating Coverage for Opill, the First Over-the-Counter Daily Oral Contraceptive Pill, Coming to Market Next Year
News ReleaseAs Opill—the first over-the-counter daily oral contraceptive pill in the United States—is expected to be available for purchase in early 2024, new research conducted by KFF examines barriers to its accessibility for consumers and challenges in providing insurance coverage for it.